lf 150195 has been researched along with Autoimmune Experimental Myasthenia Gravis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Druet, P; Duplan, V; Dutartre, P; Saoudi, A | 1 |
1 other study(ies) available for lf 150195 and Autoimmune Experimental Myasthenia Gravis
| Article | Year |
|---|---|
LF 15-0195 prevents from the development and inhibits the progression of rat experimental autoimmune myasthenia gravis.
Topics: Animals; Autoantibodies; B-Lymphocytes; Cell Differentiation; Cell Division; Disease Models, Animal; Dose-Response Relationship, Drug; Guanidines; Immunoglobulin G; Immunosuppressive Agents; Interleukins; Lymphocyte Activation; Male; Myasthenia Gravis, Autoimmune, Experimental; Rats; Rats, Inbred Lew; Receptors, Cholinergic; T-Lymphocytes | 2002 |